Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMBS
Schwab Mortgage-Backed Securities ETF
SMBS
|
+$5.08B |
| 2 |
Schwab Municipal Bond ETF
SCMB
|
+$1.29B |
| 3 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$752M |
| 4 |
Microsoft
MSFT
|
+$699M |
| 5 |
NVIDIA
NVDA
|
+$578M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$4.9B |
| 2 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$986M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$951M |
| 4 |
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
|
+$794M |
| 5 |
Schwab Fundamental International Small Company Index ETF
FNDC
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 9.33% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
iShares S&P Small-Cap 600 Value ETF
IJS
$8.35B
| $481K | ﹤0.01% |
4,830
-556
| -10% | -$52.5K |
|
3152
Eledon Pharmaceuticals
ELDN
$283M
| $480K | ﹤0.01% |
177,249
+147,262
| +491% | +$442K |
|
|
FLNA
3153
Filana Therapeutics
FLNA
$46.9M
| $480K | ﹤0.01% |
265,290
-95,963
| -27% | -$171K |
|
|
ESSA
3154
DELISTED
ESSA Bancorp
ESSA
| $477K | ﹤0.01% |
24,593
+1,547
| +7% | +$28.6K |
|
3155
C4 Therapeutics
CCCC
$429M
| $475K | ﹤0.01% |
331,897
-142,946
| -30% | -$208K |
|
3156
Monopar Therapeutics
MNPR
$772M
| $474K | ﹤0.01% |
+13,249
| New | +$481K |
|
3157
Idaho Strategic Resources
IDR
$545M
| $474K | ﹤0.01% |
+36,216
| New | +$533K |
|
|
PVLA
3158
Palvella Therapeutics
PVLA
$2.24B
| $474K | ﹤0.01% |
+21,013
| New | +$493K |
|
3159
Rocky Brands
RCKY
$357M
| $471K | ﹤0.01% |
21,205
+67
| +0.3% | +$1.28K |
|
|
CCRD
3160
DELISTED
CoreCard
CCRD
| $470K | ﹤0.01% |
+16,237
| New | +$381K |
|
3161
Corbus Pharmaceuticals
CRBP
$183M
| $470K | ﹤0.01% |
68,148
-20,377
| -23% | -$148K |
|
3162
Quad
QUAD
$509M
| $468K | ﹤0.01% |
82,830
-5,875
| -7% | -$31.8K |
|
3163
Foghorn Therapeutics
FHTX
$387M
| $461K | ﹤0.01% |
98,177
+22,682
| +30% | +$94.8K |
|
|
OPOF
3164
DELISTED
Old Point Financial
OPOF
| $461K | ﹤0.01% |
+11,745
| New | +$455K |
|
3165
Princeton Bancorp
BPRN
$290M
| $460K | ﹤0.01% |
15,073
+500
| +3% | +$15.1K |
|
3166
Electromed
ELMD
$351M
| $459K | ﹤0.01% |
+20,860
| New | +$453K |
|
3167
Avita Medical
RCEL
$252M
| $454K | ﹤0.01% |
85,817
+21,602
| +34% | +$157K |
|
3168
Evolution Petroleum
EPM
$134M
| $452K | ﹤0.01% |
96,228
+6,948
| +8% | +$31.5K |
|
|
GOOS
3169
Canada Goose Holdings
GOOS
$857M
| $452K | ﹤0.01% |
40,485
+17,792
| +78% | +$172K |
|
3170
Greene County Bancorp
GCBC
$592M
| $452K | ﹤0.01% |
20,322
+1
| +0% | +$22 |
|
3171
Medallion Financial
MFIN
$252M
| $451K | ﹤0.01% |
47,297
-3,468
| -7% | -$31.4K |
|
3172
OP Bancorp
OPBK
$235M
| $450K | ﹤0.01% |
+34,644
| New | +$422K |
|
|
HSHP
3173
Himalaya Shipping
HSHP
$729M
| $448K | ﹤0.01% |
77,725
+5,321
| +7% | +$29.7K |
|
3174
Neurogene
NGNE
$704M
| $448K | ﹤0.01% |
29,959
-4,010
| -12% | -$62.9K |
|
3175
AMES National
ATLO
$281M
| $444K | ﹤0.01% |
24,956
-1,803
| -7% | -$31.4K |
|
Similar funds
Charles Schwab's Q2 2025 Portfolio in Review
As of Q2 2025, Charles Schwab held 3,631 positions worth $578B, up 8.5% from $533B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab's Q2 2025 filing shows 158 new, 2,252 increased, 1,020 reduced and 137 closed positions. Its largest new stake was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B. The largest sale was Vanguard Mortgage-Backed Securities ETF, an estimated $4.9B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2025 buy was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B.
- Charles Schwab added most to Schwab Municipal Bond ETF in Q2 2025, an estimated $1.29B increase.
- Charles Schwab's biggest Q2 2025 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $4.9B.
- Charles Schwab fully exited Invesco FTSE RAFI US 1000 ETF in Q2 2025, selling an estimated $986M.
- Charles Schwab's ten largest holdings make up 23% of its $578B portfolio in Q2 2025.
- Charles Schwab opened 158 new positions and closed 137 in Q2 2025.
- Charles Schwab's portfolio value rose 8.5% quarter-over-quarter to $578B.
Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.